U.S. flag

An official website of the United States government

GTR Home > Laboratories > NxGen MDx

NxGen MDx

GTR Lab ID: 507143, Last updated:2023-07-13

Personnel

  • Director: Robert Carlson, MD, ABPath, Lab Director
  • Scott Pritchard, BS, Administrator
  • Casey Duld, MS, Certified Genetic counselor, CGC, Genetic Counselor

Conditions and tests

  • 3-Methylglutaconic aciduria type 32 tests
  • Abetalipoproteinaemia2 tests
  • Achromatopsia 32 tests
  • Agenesis of the corpus callosum with peripheral neuropathy2 tests
  • Alkaptonuria2 tests
  • alpha Thalassemia3 tests
  • Alpha-1-antitrypsin deficiency1 test
  • Anemia, nonspherocytic hemolytic, due to G6PD deficiency3 tests
  • Aspartylglucosaminuria2 tests
  • Ataxia-telangiectasia syndrome2 tests
  • Atelosteogenesis type II2 tests
  • Autism spectrum disorder - epilepsy - arthrogryposis syndrome2 tests
  • Autosomal recessive Alport syndrome2 tests
  • Autosomal recessive DOPA responsive dystonia2 tests
  • Autosomal recessive limb-girdle muscular dystrophy type 2D2 tests
  • Autosomal recessive limb-girdle muscular dystrophy type 2E2 tests
  • Autosomal recessive nonsyndromic hearing loss 1A2 tests
  • Autosomal recessive nonsyndromic hearing loss 42 tests
  • Autosomal recessive polycystic kidney disease2 tests
  • Bardet-Biedl syndrome 12 tests
  • Bardet-Biedl syndrome 102 tests
  • beta Thalassemia3 tests
  • Biotinidase deficiency2 tests
  • Bloom syndrome2 tests
  • Bordetella parapertussis infectious disease1 test
  • Breast cancer, susceptibility to2 tests
  • Breast-ovarian cancer, familial, susceptibility to, 11 test
  • Breast-ovarian cancer, familial, susceptibility to, 22 tests
  • Breast-ovarian cancer, familial, susceptibility to, 31 test
  • Breast-ovarian cancer, familial, susceptibility to, 41 test
  • Carcinoma of colon1 test
  • Carcinoma of pancreas1 test
  • Carnitine palmitoyl transferase 1A deficiency2 tests
  • Carnitine palmitoyl transferase II deficiency, severe infantile form2 tests
  • Charlevoix-Saguenay spastic ataxia2 tests
  • Choroideremia2 tests
  • Citrullinemia type I2 tests
  • Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency1 test
  • Classic homocystinuria2 tests
  • Classical phenylketonuria1 test
  • Cohen syndrome2 tests
  • Colorectal cancer, susceptibility to, 101 test
  • Colorectal cancer, susceptibility to, 121 test
  • Congenital amegakaryocytic thrombocytopenia2 tests
  • Congenital prothrombin deficiency3 tests
  • COVID-194 tests
  • Cystic fibrosis7 tests
  • Deficiency of alpha-mannosidase2 tests
  • Deficiency of butyryl-CoA dehydrogenase2 tests
  • Deficiency of steroid 11-beta-monooxygenase1 test
  • Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase2 tests
  • Dihydropyrimidine dehydrogenase deficiency2 tests
  • Duchenne muscular dystrophy2 tests
  • Dyskeratosis congenita, autosomal recessive 12 tests
  • Ehlers-Danlos syndrome, dermatosparaxis type2 tests
  • Endometrial carcinoma1 test
  • Enterovirus infectious disease1 test
  • Factor V deficiency1 test
  • Familial adenomatous polyposis 11 test
  • Familial adenomatous polyposis 21 test
  • Familial cancer of breast1 test
  • Familial colorectal cancer1 test
  • Familial dysautonomia5 tests
  • Familial isolated deficiency of vitamin E2 tests
  • Familial Mediterranean fever2 tests
  • Fanconi anemia complementation group C4 tests
  • Finnish congenital nephrotic syndrome2 tests
  • Fragile X syndrome7 tests
  • Galactosylceramide beta-galactosidase deficiency2 tests
  • Gaucher disease type I4 tests
  • Generalized juvenile polyposis/juvenile polyposis coli1 test
  • Glucose-6-phosphate transport defect2 tests
  • Glutaric aciduria, type 12 tests
  • Glycogen storage disease due to glucose-6-phosphatase deficiency type IA4 tests
  • Glycogen storage disease type III2 tests
  • Glycogen storage disease, type II2 tests
  • Glycogen storage disease, type V2 tests
  • GRACILE syndrome2 tests
  • Hb SS disease4 tests
  • Hereditary cancer-predisposing syndrome1 test
  • Hereditary factor XI deficiency disease2 tests
  • Hereditary fructosuria2 tests
  • Hurler syndrome2 tests
  • Hyperinsulinemic hypoglycemia, familial, 14 tests
  • Infantile hypophosphatasia2 tests
  • Influenza3 tests
  • Isovaleryl-CoA dehydrogenase deficiency2 tests
  • Joubert syndrome 24 tests
  • Junctional epidermolysis bullosa gravis of Herlitz2 tests
  • Junctional epidermolysis bullosa, non-Herlitz type2 tests
  • Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome1 test
  • Juvenile retinoschisis2 tests
  • Kugelberg-Welander disease5 tests
  • Legionnaire disease, susceptibility to1 test
  • Li-Fraumeni syndrome 11 test
  • Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency2 tests
  • Lynch syndrome 11 test
  • Lynch syndrome 41 test
  • Lynch syndrome 51 test
  • Lynch syndrome 81 test
  • Malignant tumor of prostate1 test
  • Maple syrup urine disease4 tests
  • Medium-chain acyl-coenzyme A dehydrogenase deficiency2 tests
  • Megalencephalic leukoencephalopathy with subcortical cysts1 test
  • Megalencephalic leukoencephalopathy with subcortical cysts 11 test
  • Melanoma, cutaneous malignant, susceptibility to, 21 test
  • Melanoma, cutaneous malignant, susceptibility to, 31 test
  • Metachromatic leukodystrophy2 tests
  • Metaphyseal chondrodysplasia, McKusick type2 tests
  • Microcephaly, normal intelligence and immunodeficiency2 tests
  • Mismatch repair cancer syndrome 11 test
  • MPI-congenital disorder of glycosylation2 tests
  • Mucolipidosis type IV4 tests
  • Muir-Torré syndrome1 test
  • Multiple sulfatase deficiency2 tests
  • Muscle eye brain disease2 tests
  • Mycoplasma pneumoniae pneumonia1 test
  • Nemaline myopathy 24 tests
  • Nephropathic cystinosis2 tests
  • Nephrotic syndrome, type 22 tests
  • Neu-Laxova syndrome 12 tests
  • Neuronal ceroid lipofuscinosis 12 tests
  • Neuronal ceroid lipofuscinosis 22 tests
  • Neuronal ceroid lipofuscinosis 32 tests
  • Neuronal ceroid lipofuscinosis 52 tests
  • Neuronal ceroid lipofuscinosis 82 tests
  • Niemann-Pick disease, type A4 tests
  • Niemann-Pick disease, type C12 tests
  • Pancreatic cancer, susceptibility to, 21 test
  • Pancreatic cancer, susceptibility to, 31 test
  • Pancreatic cancer, susceptibility to, 41 test
  • Parainfluenza infectious disease1 test
  • Pendred syndrome2 tests
  • Peroxisome biogenesis disorder 1A (Zellweger)2 tests
  • Perrault syndrome 12 tests
  • Pertussis1 test
  • Peutz-Jeghers syndrome1 test
  • Phenylketonuria1 test
  • Pituitary hormone deficiency, combined, 22 tests
  • PMM2-congenital disorder of glycosylation2 tests
  • Polyglandular autoimmune syndrome, type 12 tests
  • Primary hyperoxaluria, type I2 tests
  • Primary hyperoxaluria, type II2 tests
  • Pyknodysostosis2 tests
  • Pyruvate dehydrogenase E3 deficiency4 tests
  • Renal carnitine transport defect2 tests
  • respiratory syncytial virus infection2 tests
  • Retinitis pigmentosa 592 tests
  • Rhabdoid tumor predisposition syndrome 21 test
  • Rhizomelic chondrodysplasia punctata type 12 tests
  • Sialic acid storage disease, severe infantile type2 tests
  • Sialuria2 tests
  • Sjögren-Larsson syndrome2 tests
  • Smith-Lemli-Opitz syndrome2 tests
  • Spinal muscular atrophy3 tests
  • Spinal muscular atrophy, type II3 tests
  • Spongy degeneration of central nervous system5 tests
  • Tay-Sachs disease5 tests
  • Thrombophilia due to activated protein C resistance1 test
  • Tyrosinemia type I2 tests
  • Usher syndrome type 1F4 tests
  • Usher syndrome type 34 tests
  • Varicella zoster infection1 test
  • Very long chain acyl-CoA dehydrogenase deficiency2 tests
  • Werdnig-Hoffmann disease5 tests
  • Wilson disease2 tests

List of services

  • Prenatal testing
  • Carrier testing

List of certifications/licenses

Certifications

  • CLIAHelp, Number: 23D2059943, Expiration date: 2023-10-12

Licenses

  • CA - California Department of Public Health CDPH, Number: CDS00800625, Expiration date: 2022-10-08
  • MD - Maryland Department of Health and Mental Hygiene DHMH, Number: 2075, Effective date: 2018-07-01 Non-expiring
  • PA - Pennsylvania Department of Health PADOH, Number: 34962, Expiration date: 2022-08-15

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.